We can't find the internet
Attempting to reconnect
17072.1 PFLS-LS
17072.1 PFLS-LS
Zusammenfassung
Drugs Activated When Needed (DAWN)
Weitere Texte
Abstract
The use of delivery vehicles is at the basis of better tolerable and more efficacious novel classes of targeted drugs [termed Antibody- (ADC-)or Small molecule-(SMDC-)Drug Conjugates). Until now the development of ADC and SMDC relies on target cells internalization, which is difficult to measure and exploit. Here we will develop a novel and superior class of ADC and SMDC which will not require internalization of delivery vehicles and will liberate the toxic payload on demand.
Beteiligte
Martin Mattarella
Wirtschaftspartner
(martin.mattarella@philochem.ch
Philochem AG CHE-113.181.443 Martin Mattarella Libernstrasse 3 8112 Otelfingen ZH CH
Dario Neri
Kontaktperson
dario.neri@pharma.ethz.ch
ETH Zürich Inst. of Pharmac. Sciences Dario Neri HCI G496 / Wolfgang-Pauli-Strasse 10 8093 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2014-12-31
- Enddatum
- 2017-12-31
- Bewilligte Gesamtkosten
- CHF 166021.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%